Cargando…

Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis

Management of psoriasis is a challenge to the treating physician. The chronic inflammatory state of psoriasis with exacerbations and remissions necessitate “on-and-off” treatment schedules. The safety profiles of drugs and tolerability issues for patients are important factors to be considered durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Roshni, David, Brinda G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407739/
https://www.ncbi.nlm.nih.gov/pubmed/25945063
http://dx.doi.org/10.2147/CCID.S47784